Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IMI (Inverness Medical Innovations) completes buy of Apogent's Applied Biotech:

This article was originally published in Clinica

Executive Summary

Inverness Medical Innovations (IMI) has completed its acquisition of San Diego, California-based Applied Biotech, the rapid diagnostic test manufacturing subsidiary of Apogent Technologies. The deal releases Apogent from any further patent infringement claims by IMI relating to products sold by Apogent before the acquisition closed. Apogent decided to sell the unit because of its exposure to IMI's patent protection action in the fields of rapid pregnancy, drugs of abuse and infection testing (see Clinica No 1069, p 15).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063437

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel